HOME   AGENDA   SPEAKERS   PROGRAMS   INVESTORS   CAREER   PAST SUMMITS   REGISTRATION  
2019 PRE-JPM
CTIC HEALTHCARE INVESTMENT SUMMIT
JANUARY 6, 2019
SAN FRANCISCO, CA
InterContinental San Francisco
888 Howard St, San Francisco, CA 94103

SHARPENING YOUR FOCUS

Implementation of The Committee on Foreign Investment in the United States (CFIUS) on November 10, 2018, has made cross-border fundraising and partnering efforts more complicated. Precision, focus, and clarity are critical at such times when funding sources may be decreasing and the period for fundraising may be increasing.
CTIC Capital 2019 is proud to offer you strategies and connections to counter these difficulties.
Our January 2019 Summit’s Investors to Company CEO Ratio is targeted to be 2:1, with estimated 150-200 total investors attending
All of our speakers are Partners or Managing Directors of well-known firms
More than 90 percent of the 20 most active investors in cross-border investments in 2018 will be speakers or attendees of our summit
One-on-One partnering system will assist in submitting inquiries for meetings with investors and companies during the summit
New to 2019 we will also have many partners of Asian funds attending our summit
 

PARTIAL CONFIRMED SPEAKERS

RUILIN SONG (KEYNOTE)
Executive President
China Pharmaceutical Innovation and Research
Development Association (PhIRDA)
 
FENG DENG (KEYNOTE)
Founding Managing Director
Northern Light Venture Capital
 
DAVID CHEN
Chairman, HYSTA
Operating Partner, Sequoia CBC
Cross border Digital Economy Fund
 
KEVIN CHEN
Managing Partner
Biotrack Capital
 
KETING CHU
Venture Partner
LYFE Capital
 
TED DRISCOLL
Managing Director
DigitalDX Ventures
 
TAO FU
President and COO
Zai Lab
 
BOSUN HAU
Managing Director & Partner
Sailing Capital
 
FENG HAN
Managing Director
Fosun Group
 
JAMES HUANG
Managing Partner, KPCB China
Managing Partner, Panacea Venture
 
ALEXIS JI
Partner
Illumina Ventures
 
KIM KAMDAR
Partner
Domain Associates
 
NISA LEUNG
Managing Partner
Qiming Venture Partners
 
CHERRY LU
Founding & Managing Partner, Redhill Capital
Venture Partner, Sequoia Capital China
 
HONGBO LU
Partner
Lilly Asia Ventures
 
BIN LI
Partner and Managing Director
Ally Bridge Group
 
JENNY LIU
Director, Corporate Finance
Haitong International Capital Limited
 
TIMOTHY K. LU
Associate Professor of Biological
Engineering and Electrical Engineering
and Computer Science at MIT
 
XIAOBO LU
Partner
Sequoia Capital China
 
ANDREW NG
Managing Director, Head of
Healthcare, Private Equity
VMS Investment Group
 
NICK PLIAM
Partner
Decheng Capital
 
VICTOR SHI
Chairman, BayHelix
Managing Partner, Serica Partners
 
JONATHAN WANG
Partner
OrbiMed
 
VINCENT XIANG
Managing Director
Hillhouse Capital
 
KEVIN XIE
President of Fosun Healthcare Holdings
Chief Representative of Fosun US
 
LICEN XU
VP Lifecycle Leader
Roche
 
GUO-LIANG YU
Venture Partner
OrbiMed
 
JIANBIN ZHANG
Partner
IDG Capital
 
LU ZHANG
Founder and Managing Partner
Fusion Fund
 
JAMES ZHAO
Founding Partner
LYFE Capital
 
RICHARD ZHAO
Partner
Tasly Capital
 
RUILIN ZHAO
Partner
CD Capital
       
 

PARTIAL CONFIRMED INVESTMENT FIRMS

         
 

PROGRAMS

 
GENERAL ADMISSION
150-200 Asian healthcare investors
Well known investors and speakers
2: 1 Investors to Company CEO ratio
 
Healthcare Company: $499*
Service Provider: $1,099*
REGITERATION
*Current Pricing (Ends on 12/15/18)
   
  
Schedule face-to-face meetings with the most relevant Asian Healthcare Investors
Easy-to-use, Intuitive meeting scheduling platform
   
No Additional Fee. Included in General Admission
COMING SOON
   
   
PRESENTING PACKAGE
Limited spots to present to the most active Asian Investors at the Summit
Format: 10 minutes presenting plus 10 minutes investors on-stage review and discussions
   
Presenting Fee: $5,000
APPLY
INVESTOR INTRODUCTION
Targeted direct investors introductions
Prepare funds and investors background information
Facilitate face-to-face meetings during CTIC Investment Summit or JPM week*
   
Please ask for details
APPLY
*Depends on levels of selected package
 

AGENDA (Draft)

Main Summit (Main Ballroom) Presentation (Ballroom A)
MORNING SESSION
  08:00-09:00AM Breakfast / Networking
  09:00-09:15AM Welcoming Remark
    Yanhong Lin, Managing Partner, CTIC Capital
Victor Shi, BayHelix Chairmen; General Partner, Serica Partners
  09:15-10:00AM Keynote
    Ruilin Song, Executive President, China Pharmaceutical Innovation and Research Development Association (PhIRDA)
  10:00-10:45AM Panel Discussion I: Trends in Drug and Therapeutics Investment and Partnership Opportunities
    Keting Chu, Venture Partner, LYFE Capital
Hongbo Lu, Partner, Lilly Asia Ventures
James Huang, Managing Partner, KPCB China; Managing Partner, Panacea Venture
Tao Fu, President and COO, Zai Lab
Timothy Lu, Associate Professor of Biological Engineering and Electrical Engineering and Computer Science, MIT
Vincent Xiang, Managing Director, Hillhouse Capital
  10:45-11:30AM Panel Discussion II: The Age of the Cross-Border Collaborations – Opportunities and Challenges
    James Zhao, Founding Partner, LYFE Capital
Jianbin Zhang, Partner, IDG Capital
Jonathan Wang, Partner, OrbiMed
Kevin Xie, President of Fosun Healthcare Holdings, Chief Representative of Fosun US
Nisa Leung, Managing Partner, Qiming Venture Partners
Xiaobo Lu, Partner, Sequoia Capital China
  11:30-01:00PM Lunch / Special Session Hosted by WSGR: Latest CFIUS Status and Cross-Border Transactions Under Current Environment
AFTERNOON SESSION
  01:00-01:45PM Keynote
    Feng Deng, Founding Managing Director, Northern Light Venture Capital
  01:45-02:30PM Panel Discussion III
    Guo-Liang Yu, Venture Partner, OrbiMed
Kevin Chen, Managing Partner, Biotrack Capital
Jenny Liu, Director, Corporate Finance, Haitong International Capital Limited
  02:30-03:15PM Panel Discussion IV: Will Chinese Investors Continue to Pursue Investments in Medical Devices in 2019?
    Nick Pliam, Partner, Decheng Capital
Andrew Ng, Managing Director, Head of Healthcare, Private Equity, VMS Investment Group
Bin Li, Partner and Managing Director, Ally Bridge Group
Cherry Lu, Partner, Red Hill Capital
Feng Han, Managing Director, Fosun Group
  03:15-03:30PM Break
  03:30-04:15PM Panel Discussion V: Where Would Chinese Investors Invest In Vitro Diagnostics Sector Post CFIUS
    Lu Zhang, Founder and Managing Partner, Fusion Fund
Alexis Ji, Partner, Illumina Ventures
Bosun Hau, Managing Director & Partner, Sailing Capital
Ted Driscoll, Managing Director, DigitalDX Ventures
Richard Zhao, Partner, Tasly Capital
Ruilin Zhao, Partner, CD Capital
  04:15-05:15PM Surprise Session
  05:15-05:20PM Closing and Lucky Draw
 
 

PAST SUMMITS

CTIC CAPITAL

     
 
CTIC Capital is a Silicon Valley based boutique private equity consulting firm focusing on healthcare, Internet technology, and renewable energy. Leveraging our Trans-Pacific network and local expertise, CTIC Capital helps enterprises in the US and China in funding, M&A, and strategic partnership development. Our goal is to be the trusted advisor to companies for US-China cross-border investment and partnership opportunities.
 
     
 

CONTACT US

 
ning.feng@cticcapital.com
yanhong.lin@cticcapital.com